bretylium has been researched along with Hypersensitivity in 1 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MANNAIONI, PF | 1 |
| LEVI, R | 1 |
| GIOTTI, A | 1 |
1 other study available for bretylium and Hypersensitivity
| Article | Year |
|---|---|
[Anaphylaxis in the heart isolated according to the Langendorff method and treated with reserpine and bretylium].
Topics: Anaphylaxis; Bretylium Compounds; Heart; Hypersensitivity; Immune System Diseases; Reserpine; Sympat | 1961 |